Adaptive Biotechnologies Corp. (ADPT)
25.57
-0.92
(-3.47%)
USD |
NASDAQ |
Oct 12, 16:00
25.21
-0.36
(-1.41%)
After-Hours: 20:00
Adaptive Biotechnologies Free Cash Flow (Quarterly) : -7.584M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.584M |
| March 31, 2026 | -10.33M |
| December 31, 2025 | 1.419M |
| September 30, 2025 | -7.536M |
| June 30, 2025 | -13.08M |
| March 31, 2025 | -29.74M |
| December 31, 2024 | -12.57M |
| September 30, 2024 | -27.41M |
| June 30, 2024 | -19.03M |
| March 31, 2024 | -39.86M |
| December 31, 2023 | -28.23M |
| September 30, 2023 | -49.46M |
| June 30, 2023 | -27.25M |
| March 31, 2023 | -62.08M |
| December 31, 2022 | -32.56M |
| September 30, 2022 | -47.84M |
| Date | Value |
|---|---|
| June 30, 2022 | -52.36M |
| March 31, 2022 | -67.53M |
| December 31, 2021 | -63.07M |
| September 30, 2021 | -58.06M |
| June 30, 2021 | -59.25M |
| March 31, 2021 | -74.09M |
| December 31, 2020 | -49.21M |
| September 30, 2020 | -51.36M |
| June 30, 2020 | -33.34M |
| March 31, 2020 | -34.57M |
| December 31, 2019 | -29.21M |
| September 30, 2019 | -33.57M |
| June 30, 2019 | -17.49M |
| March 31, 2019 | 274.47M |
| June 30, 2018 | -10.09M |
| March 31, 2018 | -6.691M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Personalis, Inc. | -29.55M |
| 10X Genomics, Inc. | 15.39M |
| Alamar Biosciences, Inc. (California) | -15.07M |
| Champions Oncology, Inc. | -0.547M |
| Medpace Holdings, Inc. | 138.10M |